BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 18197048)

  • 21. Denys-Drash syndrome.
    Kucinskas L; Rudaitis S; Pundziene B; Just W
    Medicina (Kaunas); 2005; 41(2):132-4. PubMed ID: 15758579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A case of Denys-Drash syndrome with prophylactic bilateral nephrectomy].
    Yamamoto K; Santo Y; Satomura K
    Nihon Jinzo Gakkai Shi; 2003; 45(1):42-6. PubMed ID: 12680320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New insights into the function of the Wilms tumor suppressor gene WT1 in podocytes.
    Morrison AA; Viney RL; Saleem MA; Ladomery MR
    Am J Physiol Renal Physiol; 2008 Jul; 295(1):F12-7. PubMed ID: 18385267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel WT1 gene mutation in a patient with Wilms' tumor and 46, XY gonadal dysgenesis.
    Lee DG; Han DH; Park KH; Baek M
    Eur J Pediatr; 2011 Aug; 170(8):1079-82. PubMed ID: 21384108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel mutation of WT1 exon 9 in a patient with Denys-Drash syndrome and pyloric stenosis.
    Hu M; Craig J; Howard N; Kan A; Chaitow J; Little D; Alexander SI
    Pediatr Nephrol; 2004 Oct; 19(10):1160-3. PubMed ID: 15349765
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Refining the Diagnosis of Congenital Nephrotic Syndrome on Long-term Stored Tissue: c.1097G>A (p.(Arg366His)) WT1 Mutation Causing Denys Drash Syndrome.
    Hillen LM; Kamsteeg EJ; Schoots J; Tiebosch AT; Speel EJ; Roemen GM; Peutz-Koostra CJ; Stumpel CT
    Fetal Pediatr Pathol; 2016; 35(2):112-9. PubMed ID: 26882358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcome of renal transplantation for Wilms' tumor and Denys-Drash syndrome: a report of the North American Pediatric Renal Transplant Cooperative Study.
    Kist-van Holthe JE; Ho PL; Stablein D; Harmon WE; Baum MA
    Pediatr Transplant; 2005 Jun; 9(3):305-10. PubMed ID: 15910385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Denys-Drash syndrome].
    Kohsaka T; Tagawa M; Yamada M
    Nihon Rinsho; 2006 Sep; Suppl 3():457-64. PubMed ID: 17022587
    [No Abstract]   [Full Text] [Related]  

  • 29. A novel WT1 gene mutation in a chinese girl with denys-drash syndrome.
    Wang F; Cai J; Wang J; He M; Mao J; Zhu K; Zhao M; Guan Z; Li L; Jin H; Shu Q
    J Clin Lab Anal; 2021 May; 35(5):e23769. PubMed ID: 33942367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical and pathological features of Denys-Drash syndrome: report of 3 cases].
    Wang HY; Sun LZ; Yue ZH; Yang J; Jiang XY; Mo Y
    Zhonghua Er Ke Za Zhi; 2012 Nov; 50(11):855-8. PubMed ID: 23302619
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Donor splice-site mutations in WT1 are responsible for Frasier syndrome.
    Barbaux S; Niaudet P; Gubler MC; Grünfeld JP; Jaubert F; Kuttenn F; Fékété CN; Souleyreau-Therville N; Thibaud E; Fellous M; McElreavey K
    Nat Genet; 1997 Dec; 17(4):467-70. PubMed ID: 9398852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of Wilms' tumor genes.
    Hirose M
    J Med Invest; 1999 Aug; 46(3-4):130-40. PubMed ID: 10687307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hereditary renal tumors: Wilms' tumor--congenital anomalies' syndrome].
    Tsuchida Y; Yokomori K; Choi SH
    Nihon Rinsho; 1995 Nov; 53(11):2742-8. PubMed ID: 8538037
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemolytic uremic syndrome as the presenting manifestation of WT1 mutation and Denys-Drash syndrome: a case report.
    Alge JL; Wenderfer SE; Hicks J; Bekheirnia MR; Schady DA; Kain JS; Braun MC
    BMC Nephrol; 2017 Jul; 18(1):243. PubMed ID: 28720077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A familial WT1 mutation associated with incomplete Denys-Drash syndrome.
    Zhu C; Zhao F; Zhang W; Wu H; Chen Y; Ding G; Zhang A; Huang S
    Eur J Pediatr; 2013 Oct; 172(10):1357-62. PubMed ID: 23715653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Murine Denys-Drash syndrome: evidence of podocyte de-differentiation and systemic mediation of glomerulosclerosis.
    Patek CE; Fleming S; Miles CG; Bellamy CO; Ladomery M; Spraggon L; Mullins J; Hastie ND; Hooper ML
    Hum Mol Genet; 2003 Sep; 12(18):2379-94. PubMed ID: 12915483
    [TBL] [Abstract][Full Text] [Related]  

  • 37. WT1 Haploinsufficiency Supports Milder Renal Manifestation in Two Patients with Denys-Drash Syndrome.
    Guaragna MS; Ribeiro de Andrade JG; de Freitas Carli B; Belangero VM; Maciel-Guerra AT; Guerra-Júnior G; de Mello MP
    Sex Dev; 2017; 11(1):34-39. PubMed ID: 28081536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early presentation of bilateral gonadoblastomas in a Denys-Drash syndrome patient: a cautionary tale for prophylactic gonadectomy.
    Patel PR; Pappas J; Arva NC; Franklin B; Brar PC
    J Pediatr Endocrinol Metab; 2013; 26(9-10):971-4. PubMed ID: 23729537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Germline WT1 mutations in Wilms' tumor patients: preliminary results.
    Li FP; Breslow NE; Morgan JM; Ghahremani M; Miller GA; Grundy PE; Green DM; Diller LR; Pelletier J
    Med Pediatr Oncol; 1996 Nov; 27(5):404-7. PubMed ID: 8827066
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gonad development in Drash and Frasier syndromes depends on WT1 mutations.
    Jaubert F; Vasiliu V; Patey-Mariaud de Serre N; Auber F; Jeanpierre C; Gubler MC; Nihoul-Fékété C; Fellous M
    Arkh Patol; 2003; 65(2):40-4. PubMed ID: 15357247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.